The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Primovist, Eovist: What to expect?
Open accessAbstract
Gadolinium ethoxybenzyl dimeglumine (Gd-EOB-DTPA, Primovist in Europe and Eovist in the USA) is a liver-specific magnetic resonance imaging contrast agent that has up to 50% hepatobiliary excretion in the normal liver. After intravenous injection, Gd-EOB-DTPA distributes into the vascular and extravascular spaces during the arterial, portal venous and late dynamic phases, and progressively into the hepatocytes and bile ducts during the hepatobiliary phase. The hepatocyte uptake of Gd-EOB-DTPA mainly occurs via the organic anion transporter polypeptides OATP1B1 and B3 located at the sinusoidal membrane and biliary excretion via the multidrug resistance-associated proteins MRP2 at the canalicular membrane. Because of these characteristics, Gd-EOB-DTPA behaves similarly to non-specific gadolinium chelates during the dynamic phases, and adds substantial information during the hepatobiliary phase, improving the detection and characterization of focal liver lesions and diffuse liver disease. This information is particularly relevant for the detection of metastases, and for the detection and characterization of nodular lesions in liver cirrhosis, including early hepatocellular carcinomas. Finally, GD-EOB-DTPA-enhanced magnetic resonance imaging may provide quantitative assessment regarding liver perfusion and hepatocyte function in diffuse liver diseases. The full potential of GD-EOB-DTPA-enhanced magnetic resonance imaging has to be established further. It is already clear that GD-EOB-DTPA-enhanced magnetic resonance imaging provides anatomic and functional information in the setting of focal and diffuse liver disease that is unattainable with magnetic resonance imaging enhanced with non-specific contrast agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Forner, A., Vilana, R., Ayuso, C., Bianchi, L., Solé, M., Ayuso, J. R., Boix, L., Sala, M., Varela, M., Llovet, J. M., et al. (2008) · Hepatology · doi:10.1002/hep.21966 · Cited by 1,032
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl, T. J., Kümmel, S., Hammerstingl, R., Schellenbeck, M., Schumacher, G., Balzer, T., Schwarz, W., Müller, P. K., Bechstein, W. O., Mack, M. G., et al. (1996) · Radiology · doi:10.1148/radiology.200.1.8657946 · Cited by 453
Ringe, K. I., Husarik, D. B., Sirlin, C. B., & Merkle, E. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4392 · Cited by 388
For the European EOB-study group, Hammerstingl, R., Huppertz, A., Breuer, J., Balzer, T., Blakeborough, A., Carter, R., Fusté, L. C., Heinz-Peer, G., Judmaier, W., et al. (2008) · European Radiology · doi:10.1007/s00330-007-0716-9 · Cited by 384
Self-citationPreclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri, G., Schmitt-Willich, H., Press, W. R., Negishi, C., Weinmann, H. J., & Speck, U. (1992) · Radiology · doi:10.1148/radiology.183.1.1549695 · Cited by 380
Huppertz, A., Haraida, S., Kraus, A., Zech, C. J., Scheidler, J., Breuer, J., Helmberger, T. K., & Reiser, M. F. (2005) · Radiology · doi:10.1148/radiol.2342040278 · Cited by 370
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
Sano, K., Ichikawa, T., Motosugi, U., Sou, H., Muhi, A. M., Matsuda, M., Nakano, M., Sakamoto, M., Nakazawa, T., Asakawa, M., et al. (2011) · Radiology · doi:10.1148/radiol.11101840 · Cited by 353
Kitao, A., Zen, Y., Matsui, O., Gabata, T., Kobayashi, S., Koda, W., Kozaka, K., Yoneda, N., Yamashita, T., Kaneko, S., et al. (2010) · Radiology · doi:10.1148/radiol.10092214 · Cited by 340
Ahn, S. S., Kim, M.-J., Lim, J. S., Hong, H.-S., Chung, Y. E., & Choi, J.-Y. (2010) · Radiology · doi:10.1148/radiol.10091388 · Cited by 331
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer, P., Rummeny, E. J., Shamsi, K., Balzer, T., Daldrup, H. E., Tombach, B., Hesse, T., Berns, T., & Peters, P. E. (1996) · Radiology · doi:10.1148/radiology.199.1.8633143 · Cited by 309
Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green
de Graaf, W., Häusler, S., Heger, M., van Ginhoven, T. M., van Cappellen, G., Bennink, R. J., Kullak-Ublick, G. A., Hesselmann, R., van Gulik, T. M., & Stieger, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.047 · Cited by 304
Reimer, P., Schneider, G., & Schima, W. (2004) · European Radiology · doi:10.1007/s00330-004-2236-1 · Cited by 287
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Chen, Z., & Tiwari, A. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08235.x · Cited by 274
Tsuboyama, T., Onishi, H., Kim, T., Akita, H., Hori, M., Tatsumi, M., Nakamoto, A., Nagano, H., Matsuura, N., Wakasa, K., et al. (2010) · Radiology · doi:10.1148/radiol.10091557 · Cited by 266
Di Martino, M., Marin, D., Guerrisi, A., Baski, M., Galati, F., Rossi, M., Brozzetti, S., Masciangelo, R., Passariello, R., & Catalano, C. (2010) · Radiology · doi:10.1148/radiol.10091334 · Cited by 259
Kitao, A., Matsui, O., Yoneda, N., Kozaka, K., Shinmura, R., Koda, W., Kobayashi, S., Gabata, T., Zen, Y., Yamashita, T., et al. (2011) · European Radiology · doi:10.1007/s00330-011-2165-8 · Cited by 258
Beuers, U., Bilzer, M., Chittattu, A., Kullak-Ublick, G. A., Keppler, D., Paumgartner, G., & Dombrowski, F. (2001) · Hepatology · doi:10.1053/jhep.2001.24034 · Cited by 251
Kogita, S., Imai, Y., Okada, M., Kim, T., Onishi, H., Takamura, M., Fukuda, K., Igura, T., Sawai, Y., Morimoto, O., et al. (2010) · European Radiology · doi:10.1007/s00330-010-1812-9 · Cited by 250
Leonhardt, M., Keiser, M., Oswald, S., Kühn, J., Jia, J., Grube, M., Kroemer, H. K., Siegmund, W., & Weitschies, W. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032862 · Cited by 240
Ichikawa, T., Saito, K., Yoshioka, N., Tanimoto, A., Gokan, T., Takehara, Y., Kamura, T., Gabata, T., Murakami, T., Ito, K., et al. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181caea5b · Cited by 234
Zech, C. J., Grazioli, L., Breuer, J., Reiser, M. F., & Schoenberg, S. O. (2008) · Investigative Radiology · doi:10.1097/rli.0b013e3181705cd1 · Cited by 227
Assessment of hepatic perfusion parameters with dynamic MRI
Materne, R., Smith, A. M., Peeters, F., Dehoux, J. P., Keyeux, A., Horsmans, Y., & Van Beers, B. E. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10045 · Cited by 226
Self-citationvan Montfoort, J. E., Stieger, B., Meijer, D. K. F., Weinmann, H.-J., Meier, P. J., & Fattinger, K. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34879-7 · Cited by 223
Ronot, M., Bahrami, S., Calderaro, J., Valla, D.-C., Bedossa, P., Belghti, J., Vilgrain, V., & Paradis, V. (2011) · Hepatology · doi:10.1002/hep.24147 · Cited by 204
Motosugi, U., Ichikawa, T., Sou, H., Sano, K., Tominaga, L., Muhi, A., & Araki, T. (2010) · Radiology · doi:10.1148/radiol.10091885 · Cited by 180
Hepatobiliary transporter expression in human hepatocellular carcinoma
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Fuchsbichler, A., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01033.x · Cited by 158
Quantitative Evaluation of Liver Function with MRI Using Gd-EOB-DTPA
Ryeom, H. K., Kim, S., Kim, J.-Y., Kim, H.-J., Lee, J. M., Chang, Y., Kim, Y., & Kang, D.-S. (2004) · Korean Journal of Radiology · doi:10.3348/kjr.2004.5.4.231 · Cited by 146
Löwenthal, D., Zeile, M., Lim, W., Wybranski, C., Fischbach, F., Wieners, G., Pech, M., Kropf, S., Ricke, J., & Dudeck, O. (2010) · European Radiology · doi:10.1007/s00330-010-1977-2 · Cited by 134
Tamada, T., Ito, K., Sone, T., Yamamoto, A., Yoshida, K., Kakuba, K., Tanimoto, D., Higashi, H., & Yamashita, T. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21689 · Cited by 121
Zech, C. J., Vos, B., Nordell, A., Urich, M., Blomqvist, L., Breuer, J., Reiser, M. F., & Weinmann, H. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181a24512 · Cited by 118
Molecular classification of hepatocellular carcinoma
Zucman‐Rossi, J. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60511-7 · Cited by 109
Choi, J. S., Kim, M., Choi, J., Park, M., Lim, J. S., & Kim, K. W. (2009) · European Radiology · doi:10.1007/s00330-009-1651-8 · Cited by 99
Tsuda, N., & Matsui, O. (2010) · Radiology · doi:10.1148/radiol.10092065 · Cited by 97
BEERS, B. E. V., Materne, R., Annet, L., Hermoye, L., Sempoux, C. L., Peeters, F., Smith, A. M., Jamart, J., & Horsmans, Y. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10420 · Cited by 93
Zipprich, A., Kuß, O., Rogowski, S., Kleber, G., Lotterer, E., Seufferlein, T. T. W., Fleig, W. E., & Dollinger, M. M. (2010) · Gut · doi:10.1136/gut.2010.208595 · Cited by 92
An integrated approach to model hepatic drug clearance
Liu, L., & Pang, K. S. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.05.007 · Cited by 89
Borght, S. V., Libbrecht, L. J., Blokzijl, H., Faber, K. N., Moshage, H. J., Aerts, R., Steenbergen, W. V., Jansen, P. L. M., Desmet, V. J., & Roskams, T. (2005) · The Journal of Pathology · doi:10.1002/path.1852 · Cited by 79
Schmitt, M., Kubitz, R., Wettstein, M., Dahl, S. V., & Häussinger, D. (2000) · Biological Chemistry · doi:10.1515/bc.2000.063 · Cited by 74
Hagenbuch, B., Adler, I. ‐., & Schmid, T. E. (1999) · Biochemical Journal · doi:10.1042/bj3450115 · Cited by 70
Tsuda, N., Okada, M., & Murakami, T. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.036 · Cited by 64
Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib
Shibayama, Y., Nakano, K., Maeda, H., Taguchi, M., Ikeda, R., Sugawara, M., Iseki, K., Takeda, Y., & Yamada, K. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.433 · Cited by 60
Leiner, T., & Kucharczyk, W. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22021 · Cited by 57
Hendrikse, N. H., Kuipers, F., Meijer, C., Havinga, R., Bijleveld, C. M. A., van der Graaf, W. T. A., Vaalburg, W., & de Vries, E. G. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0793-2 · Cited by 54
Current Limitations and Potential Breakthroughs for the Early Diagnosis of Hepatocellular Carcinoma
Kim, M. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.1.15 · Cited by 39
The emerging role of transport systems in liver function tests
Stieger, B., Heger, M., de Graaf, W., Paumgartner, G., & van Gulik, T. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.048 · Cited by 37
Gupta, R. T., Marin, D., Boll, D. T., Husarik, D. B., Davis, D. E., Feuerlein, S., & Merkle, E. M. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.10.014 · Cited by 35
How Organic Anions Accumulate in Hepatocytes Lacking Mrp2: Evidence in Rat Liver
Millet, P., Sallanon, M. M., Stieger, B., Daali, Y., & Pastor, C. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175406 · Cited by 26
Self-citationBiomarkers in abdominal imaging
BEERS, B. E. V., & Vilgrain, V. (2008) · Abdominal Imaging · doi:10.1007/s00261-008-9480-9 · Cited by 25
Huppertz, A., Breuer, J., Fels, L. M., Schultze‐Mosgau, M., Sutter, G., Klein, S., Frericks, B. B., Hamm, B., & Wagner, M. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22458 · Cited by 24
Hagenbuch, B., Adler, I. ‐., & Schmid, T. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450115 · Cited by 23
Cited by
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Alves, F. C., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 420
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
Ayuso, C., Rimola, J., Vilana, R., Burrel, M., Darnell, A., García-Criado, Á., Bianchi, L., Belmonte, E., Caparroz, C., Barrufet, M., et al. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.01.025 · Cited by 394
Wald, C., Russo, M. W., Heimbach, J. K., Hussain, H. K., Pomfret, E. A., & Bruix, J. (2013) · Radiology · doi:10.1148/radiol.12121698 · Cited by 363
Self-citationMetallodrugs in cancer nanomedicine
Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259
Metadata
- Authors
- Van Beers, B. E., Pastor, C. M., & Hussain, H. K.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 57
- Issue
- 2
- Pages
- 421-429
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2163656263
- Cited by
- 407
- References
- 56
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.